Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the status of choline supplementation as a neurodevelopmental intervention for Fetal Alcohol Spectrum Disorders, currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Choline supplement (Choline)

Snippet

Sponsor: Jeff Wozniak | Conditions: Fetal Alcohol Spectrum Disorders | Phase 2 | Status: ACTIVE_NOT_RECRUITING